Giant congenital melanocytic nevus in an 8-year-old female: a case report

Authors

  • Sánchez Guevara Mariel Hospital General de Pachuca, Hidalgo, México
  • Hidalgo Ostoa Miriam Department of Genetics, Hospital General de Pachuca, Hidalgo, México
  • García Campos María Elena Department of Pediatrics, Hospital General de Pachuca, Hidalgo, México
  • Soto Piña Pamela Iiliana Hospital General de Pachuca, Hidalgo, México

DOI:

https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20242360

Keywords:

Metastatic melanoma, Giant congenital melanocytic nevus

Abstract

Giant congenital melanocytic nevus are melanocytic lesions secondary to abnormal melanoblast migration during the embryogenesis. The incidence reported is in 1 case for every 20 000 newborns and it is present since birth. The importance of its detection relies on the associated complications, such as melanoma development or neurocutaneous melanosis, as well as the psychological and social impact they generate; patients will require a long-term multidisciplinary attention. There is no elective treatment, management is still controversial, it must be individualized according to the characteristics of the nevus and the age of the patient. We present the case of an 8-year-old patient where the diagnosis of giant congenital melanocytic nevus is determined for the first time.

References

Tannous ZS, Mihm MC Jr, Sober AJ, Duncan LM. Congenital melanocytic nevi: clinical and histopathologic features, risk of melanoma, and clinical management. J Am Acad Dermatol. 2005;52(2):197-203.

Choi YS, Erlich TH, von Franque M, Rachmin I, Flesher JL, Schiferle EB, et al. Topical therapy for regression and melanoma prevention of congenital giant nevi. Cell. 2022;185(12):2071-85.

Marghoob AA, Borrego JP, Halpern AC. Congenital melanocytic nevi: treatment modalities and management options. Semin Cutan Med Surg. 2003;22(1):21-32.

Arneja JS, Gosain AK. Giant congenital melanocytic nevi of the trunk and an algorithm for treatment. J Craniofac Surg. 2005;16(5):886-93.

Arneja JS, Gosain AK. Giant congenital melanocytic nevi. Plast Reconstr Surg. 2009;124(1 Suppl):1-13.

Chien JC, Niu DM, Wang MS, Liu MT, Lirng JF, Chen SJ, et al. Giant congenital melanocytic nevi in neonates: report of two cases. Pediatr Neonatol. 2010;51(1):61-4.

D'Argenio A, David P, Engohan C, Hennequin Y, Balériaux D, Jissendi P. Neurocutaneous melanosis in a newborn with giant congenital melanocytic nevus. J Neuroradiol. 2007;34(4):272-5.

Charbel C, Fontaine RH, Malouf GG, Picard A, Kadlub N, El-Murr N, et al. NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi. J Invest Dermatol. 2014;134(4):1067-74.

Salgado CM, Basu D, Nikiforova M, Bauer BS, Johnson D, Rundell V, et al. BRAF mutations are also associated with neurocutaneous melanocytosis and large/giant congenital melanocytic nevi. Pediatr Dev Pathol. 2015;18(1):1-9.

Etchevers HC, Rose C, Kahle B, Vorbringer H, Fina F, Heux P, et al. Giant congenital melanocytic nevus with vascular malformation and epidermal cysts associated with a somatic activating mutation in BRAF. Pigment Cell Melanoma Res. 2018;31(3):437-41.

Martins da Silva V, Martinez-Barrios E, Tell-Martí G, Dabad M, Carrera C, Aguilera P, et al. Genetic Abnormalities in Large to Giant Congenital Nevi: Beyond NRAS Mutations. J Invest Dermatol. 2019;139(4):900-8.

Stark MS. Large-Giant Congenital Melanocytic Nevi: Moving Beyond NRAS Mutations. J Invest Dermatol. 2019;139(4):756-9.

Chen J, Zhang G, Liu X, Tu P. The association of BRAF V600E gene mutation with proliferative activity and histopathological characteristics of congenital melanocytic nevi in children. An Bras Dermatol. 2023;98(4):498-505.

Merkel EA, Mohan LS, Shi K, Panah E, Zhang B, Gerami P. Paediatric melanoma: clinical update, genetic basis, and advances in diagnosis. Lancet Child Adolesc Health. 2019;3(9):646-54.

Viana AC, Gontijo B, Bittencourt FV. Giant congenital melanocytic nevus. An Bras Dermatol. 2013;88(6):863-78.

Moustafa D, Blundell AR, Hawryluk EB. Congenital melanocytic nevi. Curr Opin Pediatr. 2020;32(4):491-7.

Gosain AK, Santoro TD, Larson DL, Gingrass RP. Giant congenital nevi: a 20-year experience and an algorithm for their management. Plast Reconstr Surg. 2001;108(3):622-36.

Peters R, Jansen G, Engelbrecht V. Neurocutaneous melanosis with hydrocephalus, intraspinal arachnoid collections and syringomyelia: case report and literature review. Pediatr Radiol. 2000;30(4):284-8.

Kadonaga JN, Barkovich AJ, Edwards MS, Frieden IJ. Neurocutaneous melanosis in association with the Dandy-Walker complex. Pediatr Dermatol. 1992;9(1):37-43.

Bhagwat PV, Tophakhane RS, Shashikumar BM, Noronha TM, Naidu V. Giant congenital melanocytic nevus (bathing trunk nevus) associated with lipoma and neurofibroma: report of two cases. Indian J Dermatol Venereol Leprol. 2009;75(5):495-8.

Sarkar A, Karmakar D, Saha JK, Saha Basu K, Chatterjee U, Saha K, et al. Giant Congenital Melanocytic Nevus with Congenital Neurofibroma: A Case Report. Fetal Pediatr Pathol. 2023;42(6):972-8.

Rouillé T, Aractingi S, Kadlub N, Fraitag S, How-Kit A, Daunay A, et al. Local Inhibition of MEK/Akt Prevents Cellular Growth in Human Congenital Melanocytic Nevi. J Invest Dermatol. 2019;139(9):2004-15.

Murphy BM, Burd CE. Can Combination MEK and Akt Inhibition Slay the Giant Congenital Nevus? J Invest Dermatol. 2019;139(9):1857-9.

Pozniak J, Marine JC. Treatment for giant congenital nevi moves a step closer. Cell Res. 2022;32(9):799-800.

Downloads

Published

2024-08-27

Issue

Vol. 10 No. 5 (2024): September-October 2024

Section

Case Reports